Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS10008064HBVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS30000479HIVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS30064655HIVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS30064656HIVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS20022785HPVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS20036900HPVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS20041997HPVENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS44039234HTLV-1ENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS44045259HTLV-1ENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TVIS44045369HTLV-1ENSG00000112033.14protein_codingPPARDNoNo5467Q03181
TCGA Plot Options
Drug Information
GenePPARD
DrugBank IDDB00313
Drug NameValproic acid
Target IDBE0001007
UniProt IDQ03181
Regulation Type
PubMed IDs24489787
CitationsSzalowska E, van der Burg B, Man HY, Hendriksen PJ, Peijnenburg AA: Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices. PLoS One. 2014 Jan 29;9(1):e86795. doi: 10.1371/journal.pone.0086795. eCollection 2014.
GroupsApproved; Investigational
Direct ClassificationMethyl-branched fatty acids
SMILESCCCC(CCC)C(O)=O
PathwaysValproic Acid Metabolism Pathway
PharmGKBPA451846
ChEMBLCHEMBL109